Research programme: GABA transport inhibitors - Novo Nordisk/BTGAlternative Names: GABA transport inhibitors research programme - Novo Nordisk/BTG
Latest Information Update: 10 Jul 2002
At a glance
- Originator Novo Nordisk
- Developer BTG
- Mechanism of Action GABA uptake inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Epilepsy; Pain
Most Recent Events
- 24 Feb 1999 New profile
- 24 Feb 1999 Preclinical development for Epilepsy in United Kingdom (Unknown route)
- 24 Feb 1999 Preclinical development for Pain in United Kingdom (Unknown route)